Radiation therapy is used to kill cancer cells with high-energy x-ray beams. You may receive radiation therapy from outside your body or from small beads or rods placed inside your prostate. Surgery may be needed, depending on the stage of the cancer. Part or all of your prostate may be...
Development of a Spherical 125 I-Brachytherapy Seed for Its Application in the Treatment of Eye and Prostate Cancer Palladium-coated silver beads of 0.5 mm (phi) were used to adsorb (125)I, encapsulated inside a titanium capsule by an Nd:YAG laser, for use as a brachytherapy source. Experim...
In contrast, serum PSA levels demonstrated that all but one patient had responded well to treatment, with levels below 1.5 ng/ml at 6 months post treatment. There was no correlation between this surrogate cancer-marker, and the quantity of urinary exosomes. One may speculate that the reduction...
Prostate cancer is the second most commonly diagnosed cancer among men with an estimated 1.3 million new cases worldwide in 20181. Although most men diagnosed with primary prostate cancer are treated with curative intent through surgery or radiation therapy, treatments fail in 30% of patients within...
After 5 weeks of treatment without chemo, radiation, or biopsy, I returned home. The following year, I returned to the clinic and had repeated testing that showed NO tumors, prostate normal and no sign of cancer. I’m very grateful to my son Albert for support and getting me to Dr. ...
Prostate cancer is the second most common malignancy in men worldwide and consists of a mixture of tumor and non-tumor cell types. To characterize the prostate cancer tumor microenvironment, we perform single-cell RNA-sequencing on prostate biopsies, prostatectomy specimens, and patient-derived organo...
A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond to treatment and survive the longest. It can help providers decide which patients should receive standard treatment versus who might stand to benefit from riskier, more aggress...
treatment in prostate cancer cells. In addition, we found that USP3 expression is up-regulated in prostate cancer tissues and positively with SMARCA5 expression. Moreover, USP3 knockdown sensitizes cancer cells to DNA-damaging agents in xenograft models, suggesting that the USP3- SMARCA5 axis ...
The treatment of low-risk primary prostate cancer entails active surveillance only, while high-risk disease requires multimodal treatment including surgery, radiation therapy, and hormonal therapy. Recurrence and development of metastatic disease remains a clinical problem, without a clear understanding of ...
The present invention provides an improved diagnostic test for prostate cancer which has a relatively high potential for metastasis or which has metastasized. This allows the physician to choose appropriate surgical, chemotherapeutic or radiation treatment regimens. This improved assay is based on the cor...